Haisco Pharmaceutical Group Co., Ltd. Haisco Pharmaceutical Group Co., Ltd.

Haisco Pharmaceutical Group Co., Ltd.

002653

株式のランク #2077
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
株価
$8.74
時価総額
$9.97B
変化(1日)
1.17%
変化(1年)
20.15%
国
CN
取引 Haisco Pharmaceutical Group Co., Ltd. (002653)

カテゴリー

Healthcare
Haisco Pharmaceutical Group Co., Ltd.(002653)の配当利回りの履歴
Haisco Pharmaceutical Group Co., Ltd.(銘柄コード: 002653)の配当利回り(TTM)は2023-12-31時点で0.16%です。
過去5年間の平均配当利回り: 0.89%
Haisco Pharmaceutical Group Co., Ltd.(002653)の2008から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
年 配当利回り 変化
2026 (TTM) 1.42% 25.66%
2024 1.13% 606.25%
2023 0.16% -80.72%
2022 0.83% -54.40%
2021 1.82% 243.40%
2020 0.53% -43.01%
2019 0.93% -65.30%
2018 2.68% -40.31%
2017 4.49% 162.57%
2016 1.71% 72.73%
2015 0.99% -35.29%
2014 1.53% 7.75%
2013 1.42% -35.16%
2012 2.19% 21,800.00%
2011 0.01% -99.45%
2010 1.83% -58.31%
2009 4.39% 14,533.33%
2008 0.03% 0.00%
類似企業または競合他社の配当利回り(TTM)